title: Benign intracranial hypertension in association with acute lymphoblastic leukemia.
authors.affiliation: Department of Pediatric Oncology, Llandough Hospital, Cardiff, UK.
authors.forename: J
authors.initials: J
authors.lastname: Sastry
authors.forename: S S
authors.initials: SS
authors.lastname: Karandikar
authors.forename: M W E
authors.initials: MW
authors.lastname: English
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage / Q000627:therapeutic use; D002752:Chlorthalidone / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006261:Headache / Q000209:etiology; D006801:Humans; D019586:Intracranial Hypertension / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012851:Sinus Thrombosis, Intracranial / Q000175:diagnosis; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use; D014839:Vomiting / Q000209:etiology
chemical_list: D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D001215:Asparaginase; D000086:Acetazolamide; D002752:Chlorthalidone; D008727:Methotrexate; D003630:Daunorubicin